CD63+ cancer-associated fibroblasts confer CDK4/6 inhibitor resistance to breast cancer cells by exosomal miR-20-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

CD63+ cancer-associated fibroblasts confer CDK4/6 inhibitor resistance to breast cancer cells by exosomal miR-20

Published:2024-04 Issue: Volume:588 Page:216747
ISSN:0304-3835
Container-title:Cancer Letters
language:en
Short-container-title:Cancer Letters

Author:

Sun Jiahui,Du Ruoxin,Li Xiaoju,Liu Chenlin,Wang Donghui,He Xiangmei,Li Guodong,Zhang Kuo,Wang Shuning,Hao Qiang,Zhang Yingqi,Li Meng,Gao Yuan,Zhang Cun

Funder

National Natural Science Foundation of China

Natural Science Basic Research Program of Shaanxi Province

Science Fund for Distinguished Young Scholars of Tianjin Municipality

Publisher

Elsevier BV

Reference48 articles.

1. Breast cancer: an up-to-date review and future perspectives;Hong;Cancer Commun.,2022

2. Long non-coding RNA mediated drug resistance in breast cancer;Singh;Drug Resist. Updates,2022

3. Targeting CDK4 and CDK6 in cancer;Goel;Nat. Rev. Cancer,2022

4. NCCN guidelines updates: breast cancer;Telli;J. Natl. Compr. Cancer Netw.,2019

5. Inhibiting CDK4/6 in breast cancer with palbociclib, ribociclib, and abemaciclib: similarities and differences;Braal;Drugs,2021

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Molecular insights to therapeutic in cancer: role of exosomes in tumor microenvironment, metastatic progression and drug resistance;Drug Discovery Today;2024-08

2. Targeting STAT3 potentiates CDK4/6 inhibitors therapy in head and neck squamous cell carcinoma;Cancer Letters;2024-07

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP